Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 16 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact16 DOIs

DOIs for this ISSN

Showing the top 5 of 198 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Requiem for Rimonabant: Therapeutic Potential for Cannabinoi… (10.3390/ddc2030035)	ORCID	30.10	15
2	Drug Candidates for the Treatment of Alzheimer’s Disease: Ne… (10.3390/ddc2030030)	ORCID	27.85	12
3	Design, Synthesis and In Vitro Studies of 3-Amidocoumarins a… (10.3390/ddc2020015)	ORCID	21.13	6
4	Date (Phoenix dactylifera L.) Fruits as a Potential Lipid-Lo… (10.3390/ddc2020021)	ORCID	21.13	6
5	Selinexor and Other Selective Inhibitors of Nuclear Export (… (10.3390/ddc2020023)	ORCID	21.13	6
6	Bradykinin-Mediated Angioedema Induced by Commonly Used Card… (10.3390/ddc2030036)	ORCID	21.13	6
7	Epigenetic Alterations in Cancer: The Therapeutic Potential… (10.3390/ddc4020015)	ORCID	19.45	5
8	Harnessing Bacillus subtilis Spore Surface Display (BSSD) Te… (10.3390/ddc3040044)	ORCID	17.47	4
9	Cyclophosphamide: Old Drug with Great Future (10.3390/ddc4040048)	ORCID	15.05	3
10	Bradykinin Receptors in Metabolic Disorders: A Comprehensive… (10.3390/ddc4030037)	ORCID	7.53	1
11	Computational Screening of AI-Generated Antihypertensive Vir… (10.3390/ddc5010016)	ORCID	7.53	1
12	Drugs and Drug Candidates: A Challenging Project (10.3390/ddc1010001)		0.00	2
13	Synthesis, Selective Cytotoxic Activity against Human Breast… (10.3390/ddc1010002)		0.00	16
14	Failed Repurposing of Lysosomotropic Drugs for COVID-19 Trea… (10.3390/ddc1010003)		0.00	0
15	Xanthene Derivatives Targeting Bacterial Efflux Pumps, Quoru… (10.3390/ddc1010004)		0.00	10
16	Synthesis, Characterization, and Activity of Hydroxymethylni… (10.3390/ddc1010005)		0.00	2
17	Angiogenesis under Opioids Preconditioning in Renal Ischemia… (10.3390/ddc2010001)		0.00	0
18	Indonesian Vegetables: Searching for Antioxidant and Antidia… (10.3390/ddc2010002)		0.00	3
19	Isolation and Characterization of Prophylactic Antimalarial… (10.3390/ddc2010003)		0.00	5
20	Betulinic Acid: Triterpenoid Derivative Induced NADPH-d Expr… (10.3390/ddc2010004)		0.00	3
21	Testolactone: The Rise and Fall of a Drug (10.3390/ddc2010005)		0.00	11
22	Stearylamine Liposome as an Anti-Parasitic Agent (10.3390/ddc2010006)		0.00	15
23	An Investigation on the Relationships between Mass Spectrome… (10.3390/ddc2010007)		0.00	0
24	Do Certain Anaesthetic Drugs Affect Postoperative Cancer Rec… (10.3390/ddc2010008)		0.00	1
25	Pharmacological Blockade of TGF-Beta Reduces Renal Interstit… (10.3390/ddc2010009)		0.00	5
26	Recent Developments in Electrospun Nanofibers as Delivery of… (10.3390/ddc2010010)		0.00	30
27	A Review of the Patentability of Rosemary-Derived Drugs and… (10.3390/ddc2010011)		0.00	20
28	Optimizing Protein Production in Therapeutic Phages against… (10.3390/ddc2010012)		0.00	11
29	A Systematic Review of Molecular Pathway Analysis of Drugs f… (10.3390/ddc2020013)		0.00	1
30	Therapeutic Perspectives of Metal Nanoformulations (10.3390/ddc2020014)		0.00	10
31	Synergistic Interaction of Glycyrrhizin with Norfloxacin Dis… (10.3390/ddc2020016)		0.00	7
32	Virtual Screening Algorithms in Drug Discovery: A Review Foc… (10.3390/ddc2020017)		0.00	129
33	The Readiness to Harness the Floristic Uniqueness of Mauriti… (10.3390/ddc2020018)	ORCID	0.00	0
34	Reduction of Cancer Stem Cells and Invasiveness of Human Mel… (10.3390/ddc2020019)		0.00	3
35	How Far Have We Developed Antibody–Drug Conjugate for the Tr… (10.3390/ddc2020020)		0.00	4
36	Effect of the N501Y Mutation on Ligands Complexed with SARS-… (10.3390/ddc2020022)		0.00	1
37	In Vitro Evaluation of Arylsulfonamide Derivatives against T… (10.3390/ddc2020024)		0.00	0
38	The (–)-Borneol Effect on Addiction/Abstinence by Morphine i… (10.3390/ddc2020025)		0.00	0
39	Antimicrobial Nanoformulations Based on Schinus areira Essen… (10.3390/ddc2020026)		0.00	6
40	Black Cumin Seed (Nigella sativa) in Inflammatory Disorders:… (10.3390/ddc2020027)		0.00	28
41	Drugs of the Kallikrein–Kinin System: An Overview (10.3390/ddc2030028)		0.00	8
42	Algal Nanoparticles and Their Antibacterial Activity: Curren… (10.3390/ddc2030029)		0.00	42
43	MET-Targeting Anticancer Drugs—De Novo Design and Identifica… (10.3390/ddc2030031)		0.00	2
44	Inhibitors of Farnesyl Diphosphate Synthase and Squalene Syn… (10.3390/ddc2030032)		0.00	4
45	Synthesis and Antimalarial Evaluation of New 1,3,5-tris[(4-(… (10.3390/ddc2030033)		0.00	6
46	Schlesinger Nailed It! Assessing a Key Primary Pharmacodynam… (10.3390/ddc2030034)		0.00	6
47	Unmasking the Warburg Effect: Unleashing the Power of Enzyme… (10.3390/ddc2030037)		0.00	16
48	Preformulation Studies of Novel Menthol Prodrugs with Antipa… (10.3390/ddc2030038)		0.00	7
49	Bioactive Components of Myracrodruon urundeuva against SARS-… (10.3390/ddc2040039)		0.00	4
50	Identification of Potential Non-Systemic Therapeutics for Hy… (10.3390/ddc2040040)		0.00	0